AVBCC COVID-19 Webcast Series
By Elizabeth Franklin, LGSW, ACSW; Patricia J Goldsmith; Amy Niles, MBA; Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG; Burt Zweigenhaft, PhD, D.Litt
As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.
Read ArticleBy Scott Freeswick, MS, PharmD; Niesha Griffith, RPh, MS, FASHP; Chris Marcum, PharmD; Ali McBride, PharmD, MBA; Stacey McCullough, PharmD; Bhavesh Shah, RPh, BCOP; Burt Zweigenhaft, PhD, D.Litt
Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.
Read ArticleThe COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?
Read ArticleAs we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?
Read ArticleBy Roger Brito, DO; Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN; Michael Kolodziej, MD; Barbara L. McAneny, MD; Steven Peskin, MD, MBA, FACP; Chevon Rariy, MD; Burt Zweigenhaft, PhD, D.Litt
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?
Read ArticleBy David DeRemer, PharmD, BCOP, FCCP, FHOPA; Michael Joyner, MD; Maurie Markman, MD; Kevin O’Hayer, MD, PhD; Bhavesh Shah, RPh, BCOP; Mark Sloan, MD; Burt Zweigenhaft, PhD, D.Litt
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?
Read ArticleThe COVID-19 pandemic will have far-reaching economic implications in the United States and abroad for the foreseeable future. During this session Murray Aitken, MBA, Director, IQVIA Institute, presented emerging data regarding some of the ways in which the pandemic is affecting the US economy.
Read ArticleBurt Zweigenhaft, PhD, D.Litt, Founder, Association for Value-Based Cancer Care, moderated a panel session in which 3 experts from the independent actuarial firm, Milliman, discussed recent data showing the ways in which the COVID-19 pandemic may affect the future of healthcare.
Read ArticleBy Gabriela Dieguez, FSA, MAAA; Pamela Pelizzari, MPH; Bruce S. Pyenson, FSA, MAAA; Burt Zweigenhaft, PhD, D.Litt
In this webcast, 3 experts from the independent actuarial firm, Milliman, discussed data on the impact of the COVID-19 pandemic on insurance utilization and costs. The panel explored several factors that may lead to healthcare reform in the months ahead, including the way in which patients and providers approach deferred or avoidable care.
Read ArticleThe federal government is an active participant in shaping and delivering healthcare policy. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.
Read Article